L’Oréal – Nestlé launch first rival to Botox

Published: 18-May-2009

Following the marketing approval from 15 EU member states in February, Galderma, the joint venture between Nestle and L'Oréal has launched its botulic toxin Azzalure in the UK after the British Health Regulators approved Azzalure for use as a cosmetic product. According to Galderma, which is marketing the Azzalure brand under license from French manufacturer Ipsen, the product is now ready to be marketed. Ipsen is reported to have marketed the product under the brand Dysport for therapeutic treatments for a number of years.

The toxin was originally 
developed by Allergan in the US and is considered to be the first direct rival to Botox. Like Botox, it is a botulinum that is injected into the skin and prevents the temporarily contraction of muscles that cause fine lines and wrinkles. The product particularly targets the vertical lines between the eyebrows. The brand is hoping to attract a broad market with the product.

Allergan, the maker of Botox, has forecast that globa


Following the marketing approval from 15 EU member states in February, Galderma, the joint venture between Nestle and L'Oréal has launched its botulic toxin Azzalure in the UK after the British Health Regulators approved Azzalure for use as a cosmetic product. According to Galderma, which is marketing the Azzalure brand under license from French manufacturer Ipsen, the product is now ready to be marketed. Ipsen is reported to have marketed the product under the brand Dysport for therapeutic treatments for a number of years.

The toxin was originally 
developed by Allergan in the US and is considered to be the first direct rival to Botox. Like Botox, it is a botulinum that is injected into the skin and prevents the temporarily contraction of muscles that cause fine lines and wrinkles. The product particularly targets the vertical lines between the eyebrows. The brand is hoping to attract a broad market with the product.

Allergan, the maker of Botox, has forecast that global sales of Botox will reach almost $1.2bn this year and Azzalure certainly has the potential to gain its share of the market.

Last year there were 5 million cosmetic Botox treatments in the US alone and worldwide this practice is becoming more socially acceptable.

See more

You may also like

Regulatory

Linda Evangelista blames CoolSculpting nightmare on commercials shown ‘over and over’

Read more
In a British Vogue interview, the supermodel confessed to liking the concept of no downtime or surgery; but what does excessive promotion of treatments mean for vulnerable consumers?

Trending Articles

  1. Seen snaps up former Ulta Beauty boss as Chief Marketing Officer Linh Peters previously served as Head of Loyalty Marketing and Strategy at Ulta Beauty, overseeing the US beauty retailer’s loyalty programme and personalisation engine
  2. L'Oréal, LVMH and Luxottica named preferred buyers of Giorgio Armani empire The late Italian fashion designer has given purchasing priority to L'Oréal, along with LVMH, owned by the world’s richest man, Arnault Bernard, and eyewear brand Luxottica
  3. Glossier names Colin Walsh CEO as it aims to become ‘a true legacy brand’ Walsh, who has previously helmed the beauty divisions of Ouai and Procter & Gamble, will join the beauty company in October
  4. You need to be a subscriber to read this article.
    Click here to find out more.
    Maison Francis Kurkdjian turns heads with new $28,000 bottle of Baccarat Rouge 540 The fragrance giant has shocked consumers with its latest launch. Only 54 bottles of new Baccarat Rouge 540 Édition Millésime will be created each year, housed in a red crystal bottle with a 24-carat gold cap
  5. La Roche-Posay lands Law Roach for punny partnership marking 50th anniversary The L’Oréal-owned skin care brand has brought in the celebrity stylist alongside a cast of experts and creators for its ‘Brand Name’ Campaign in an attempt to connect with younger generations

Upcoming event

13th Annual Beauty Trends & Innovations Conference

24 September 2025 | London, UK See all

You may also like

Regulatory

Linda Evangelista blames CoolSculpting nightmare on commercials shown ‘over and over’

In a British Vogue interview, the supermodel confessed to liking the concept of no downtime or surgery; but what does excessive promotion of treatments mean for vulnerable consumers?
Finance

Nestle trims back stake in L’Oréal for 9 billion euros

Swiss food giant will retain Board positions and is ‘fully supportive’ of cosmetic company’s direction
Regulatory

Linda Evangelista says she has been 'brutally disfigured' by cosmetic treatment

The Canadian supermodel rose to fame in the 1990s, but claims her career is now on hold due to Allergan's CoolSculpting fat freezing procedure
You need to be a subscriber to read this article.
Click here to find out more.
Body Care

Actress Malin Akerman appointed as Ambassador for CoolSculpting

The ‘Rampage’ and ‘Couples Retreat’ actress has been named the first Allergan Aesthetics body contouring partner
Regulatory

Botox battle: Allergan attempts to block sale of injectables competitor in US market with support of ITC

The US’ International Trade Commission agreed that Daewoong’s rival product, Jeuveau, was unfairly sold in the US market, however, the full details of the decision have not yet been disclosed
You need to be a subscriber to read this article.
Click here to find out more.
Body Care

Cosmetic doctor Tijion Esho hosts podcast telling of return to NHS frontline

The episode, From Fillers to Frontline, features two other cosmetic and aesthetic surgeons who have also been helping the NHS during the Covid-19 pandemic
Skin Care

Nestlé sells Skin Health business in billion-pound deal

Brands including Proactive and Cetaphil have been sold to a consortium led by investment company EQT and a subsidiary of the Abu Dhabi Investment Authority
Subscribe now